ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
Oral BPC-157 For Potential Gut Health
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="BadassBlues" data-source="post: 271870" data-attributes="member: 38526"><p>A brief history and bio of the doctor who discovered BPC-157</p><p></p><p>[URL unfurl="true"]https://international.pte.hu/honorary-doctors/prof-dr-predrag-sikiric[/URL]</p><p></p><h4>Predrag Sikirić is honorary doctor of the University of Pécs since 16 November 2017.</h4><p><strong>Department of Pharmacology, Medical University of Zagreb, Croatia </strong></p><p><strong></strong></p><p><strong>Predrag Sikiric</strong> MD,PhD is professor at the Department of Pharmacology, Medical University of Zagreb, Croatia.</p><p></p><p>He and his team discovered an peptide in the human gastric juce, which prevents the development of gastric mucosal damage (without any inhibitory effect on gastric acid secretion). This molecule was isolated and the sequence of amino acids was identifield. This molecule acts in very small doses, and it has no toxic behaviour. Later, he and his coworkers proved the mucosal protecting effects on the other parts of gastrointestinal tract in animal experiments and human studies. Now this molecule exists in different human clinical pharmacological phase examinations in patients with ulcerative colitis and sclerosis multiplex. This active peptide compound was named as “Body Protection Compound, BPC”.</p><p></p><p>Our scientific collaboration started from 1989, and it’s existing up to now. We together organized international symposia of International Conferences on Ulcer Researh and of International Union of Pharmacology, Gastrointestinal Section (IUPHAR GI SECTION) in Hungary (Budapest, Pécs) and Croatia (Zagreb, Dubrovnik, Split). We together established the international journal (Pergamon Press Publishers) “Experimental and Clinical Gastroenteroloy” (1990).</p><p></p><p>We have principle roles in the establishing of possibilities for Hungary and Croatia to participate in the World scientific collaboration in our fields , namely ulcer research.</p><p></p><p>Professor Sikiric and his studies internationally well know and accepted.</p></blockquote><p></p>
[QUOTE="BadassBlues, post: 271870, member: 38526"] A brief history and bio of the doctor who discovered BPC-157 [URL unfurl="true"]https://international.pte.hu/honorary-doctors/prof-dr-predrag-sikiric[/URL] [HEADING=3]Predrag Sikirić is honorary doctor of the University of Pécs since 16 November 2017.[/HEADING] [B]Department of Pharmacology, Medical University of Zagreb, Croatia Predrag Sikiric[/B] MD,PhD is professor at the Department of Pharmacology, Medical University of Zagreb, Croatia. He and his team discovered an peptide in the human gastric juce, which prevents the development of gastric mucosal damage (without any inhibitory effect on gastric acid secretion). This molecule was isolated and the sequence of amino acids was identifield. This molecule acts in very small doses, and it has no toxic behaviour. Later, he and his coworkers proved the mucosal protecting effects on the other parts of gastrointestinal tract in animal experiments and human studies. Now this molecule exists in different human clinical pharmacological phase examinations in patients with ulcerative colitis and sclerosis multiplex. This active peptide compound was named as “Body Protection Compound, BPC”. Our scientific collaboration started from 1989, and it’s existing up to now. We together organized international symposia of International Conferences on Ulcer Researh and of International Union of Pharmacology, Gastrointestinal Section (IUPHAR GI SECTION) in Hungary (Budapest, Pécs) and Croatia (Zagreb, Dubrovnik, Split). We together established the international journal (Pergamon Press Publishers) “Experimental and Clinical Gastroenteroloy” (1990). We have principle roles in the establishing of possibilities for Hungary and Croatia to participate in the World scientific collaboration in our fields , namely ulcer research. Professor Sikiric and his studies internationally well know and accepted. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
Oral BPC-157 For Potential Gut Health
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top